Comparison of Cutting Balloon Angioplasty and Percutaneous Balloon Angioplasty of Arteriovenous Fistula Stenosis: A Meta‐Analysis and Systematic Review of Randomized Clinical Trials

Agarwal, Shiv Kumar; Nadkarni, Girish N.; Yacoub, Rabi; Patel, Achint; Jenkins, J. Stephen; Collins, Tyrone J.; Annapureddy, Narender; Kumbala, Damodar; Bodana, Shirisha; Benjo, Alexandre

doi:10.1111/joic.12202

Cited by 50 publications

(35 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In their response to Connolly et al questioning the soundness of methodology used by Agarwal et al in lumping AV grafts and AV fistulas in their meta‐analysis, Agarwal and Nadkarni made an inaccurate reference to our study by reversing our study data. They incorrectly stated that our study showed that cutting balloon group had a numerically higher patency at 3, 6, and 12 months.…”

mentioning

confidence: 88%

Response: Letter to the Editor and Response: Comparison of Cutting Balloon Angioplasty and Percutaneous Balloon Angioplasty of Arteriovenous Fistula Stenosis: A Meta‐Analysis and Systematic Review of Randomized Clinical Trials

Rasuli

Connolly

2016

J Interven Cardiology

View full text Add to dashboard Cite

mentioning

confidence: 88%

Response: Letter to the Editor and Response: Comparison of Cutting Balloon Angioplasty and Percutaneous Balloon Angioplasty of Arteriovenous Fistula Stenosis: A Meta‐Analysis and Systematic Review of Randomized Clinical Trials

Rasuli

Connolly

2016

J Interven Cardiology

View full text Add to dashboard Cite

“…In the arterial system, stenotic lesions are commonly due to atherosclerosis where oxidative stress and inflammation trigger cholesterol deposition and cell proliferation in the intima [1]. Stenosis also occurs in the venous system, typically due to previous trauma such as placement of in-dwelling catheters [2], cardiac rhythm transvenous devices, synthetic arteriovenous hemodialysis grafts [3] and creation of native hemodialysis fistulas[4, 5]. The stenotic lesions that occur in the venous system differ from arterial atherosclerotic lesions as they typically do not have cholesterol plaques, necrotic cores or foam cells, and consist mostly of smooth muscle and/or myofibroblast cells [6].…”

Section: Introductionmentioning

confidence: 99%

Autologous fat transplants to deliver glitazone and adiponectin for vasculoprotection

Sanders

Zhuplatov

et al. 2017

Journal of Controlled Release

View full text Add to dashboard Cite

The insulin sensitizing glitazone drugs, rosiglitazone (ROS) and pioglitazone (PGZ) both have anti-proliferative and anti-inflammatory effects and induce adipose tissue (fat) to produce the vaso-protective protein adiponectin. Stenosis due to intimal hyperplasia development often occurs after placement of arteriovenous synthetic grafts used for hemodialysis. This work was performed to characterize the in vitro and in vivo effects of ROS or PGZ incorporation in fat and to determine if fat/PGZ depots could decrease vascular hyperplasia development in a porcine model of hemodialysis arteriovenous graft stenosis. Powdered ROS or PGZ (6–6000 μM) was mixed with fat explants and cultured. Drug release from fat was quantified by HPLC/MS/MS, and adiponectin and monocyte chemotactic protein-1 (MCP-1) levels in culture media were measured by ELISA. The effect of conditioned media from the culture of fat with ROS or PGZ on i) platelet-derived growth factor-BB (PDGG-BB)-stimulated proliferation of human venous smooth muscle cells (SMC) was measured by a DNA-binding assay, and ii) lipopolysaccharide (LPS)-induced human monocyte release of tumor necrosis factor-alpha (TNFα) was assessed by ELISA. In a porcine model, pharmacokinetics of PGZ from fat depots transplanted perivascular to jugular vein were assessed by HPLC/MS/MS, and retention of the fat depot was monitored by MRI. A porcine model of synthetic graft placed between carotid artery and ipsilateral jugular vein was used to assess effects of PGZ/fat depots on vascular hyperplasia development. Both ROS and PGZ significantly induced the release of adiponectin and inhibited release of MCP-1 from the fat. TNF production from monocytes stimulated with LPS was inhibited 50–70% in the presence of media conditioned by fat alone or fat and either drug. The proliferation of SMC was inhibited in the presence of media conditioned by fat/ROS cultures. Fat explants placed perivascular to the external jugular vein were retained, as confirmed by MRI at one week after placement. PGZ was detected in the fat depot, in the external jugular vein wall and in adjacent tissue at clinically relevant levels, whereas levels in plasma were below detection. External jugular vein exposed to fat incorporated with PGZ had increased adiponectin expression compared to vein exposed to fat alone. However, the development of hyperplasia within the arteriovenous synthetic grafts was unchanged by treatment with fat/PGZ depots compared to no treatment.

show abstract

“…The recent study by Agarwal et al . concluded that treatment of hemodialysis access stenoses with percutaneous cutting balloon angioplasty resulted in higher long‐term patency at 6 months compared to conventional balloon angioplasty . However, considerable heterogeneity between the patient populations of the three included studies warrants re‐considering this conclusion …”

mentioning

confidence: 99%

“…compared cutting and high‐pressure balloon angioplasty exclusively in patients with AV grafts, not AV fistulas. The title of Agarwal et al 's study uses ‘arteriovenous fistula’ which could be considered misleading when patients with AV grafts are included in two of the studies …”

mentioning

confidence: 99%

“…The title of Agarwal et al's study uses 'arteriovenous fistula' which could be considered misleading when patients with AV grafts are included in two of the studies. 1,2,4 In summary, Agarwal et al identified several limitations including differences in assessment of patency, definitions of procedural success and length of follow up. 1 However, we believe the most important limitation is the considerable heterogeneity between (and within) each of the patient populations in the three studies, specifically access type (AV fistulas versus AV grafts) and selection of resistant stenosis.…”

mentioning

confidence: 99%

See 1 more Smart Citation